Emerging Diseases
ACIP Recommends Bavarian Nordic’s Chikungunya Vaccine
The ACIP voted to recommend the Vimkunya vaccine for certain populations. However, the CDC has not acted yet on this or other recommendations the ACIP made April 16.
APRIL 25, 2025
How Close Is H5N1 to Reaching the Goal?
If H5N1 were on a soccer team, as one expert described it, it just might be able to score a goal: human-to-human transmission.
APRIL 24, 2025
Chikungunya Fever Can Lead to RA
A significant proportion of patients with chikungunya fever develop rheumatoid arthritis (RA) following infection with the chikungunya virus, according to a recent meta-analysis.
APRIL 24, 2025
Possible Threats from the Defrosting Permafrost
As temperatures rise and the permafrost melts, animals and people could be exposed to new organisms—either ones that they have never encountered before or that are quite different from the modern versions of these pathogens.
FEBRUARY 18, 2025
Immune Antibody Appears Protective Against H5N1 in Monkeys
A prophylactic antibody-based immune therapy protects macaques against severe disease caused by H5N1 avian flu, according to University of Pittsburgh and NIH Vaccine Research Center researchers.
JANUARY 31, 2025
Despite Mutations, Avian Flu Still Susceptible to Antivirals
Researchers identified nine mutations in an avian influenza strain from a person in Texas.
JANUARY 29, 2025
‘Many Barriers to Success’ Make It Difficult to Control Avian Flu
Wild birds like ducks and geese can migrate thousands of miles, infecting wild and domestic animals, which is one reason it has been so difficult to stop avian flu outbreak among farm animals, according to experts who spoke at an IDSA briefing.
JANUARY 10, 2025
Mystery Flu-Like Illness Kills At Least 79 in DRC
An unknown flu-like illness has killed at least 79 people in a remote section of the Democratic Republic of the Congo.
DECEMBER 5, 2024
Tecovirimat is Safe but Did Not Improve Clade I Mpox Resolution in the DRC
The antiviral drug tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I mpox in the Democratic Republic of the Congo (DRC), based on an initial analysis of data from a randomized, placebo-controlled trial.
SEPTEMBER 9, 2024
Los Angeles County Tecovirimat Distribution Plan Aided in Mpox Response
The distribution of tecovirimat through hospitals, clinics and pharmacies during the 2022-2023 mpox outbreak was more efficient using a hub-and-spoke distribution network.
AUGUST 7, 2024
CDC Confirms Human Cases of H5 Bird Flu Among Colorado Poultry Workers
The CDC confirmed four human cases of highly pathogenic avian influenza virus infection in Colorado. The CDC also is aware of a fifth presumptive-positive case in Colorado that will be confirmed at the CDC once the specimen arrives.
JULY 16, 2024
Mpox Still Circulating In Low Numbers Among MSM
Low-level transmission of mpox is still occurring, primarily among gay and bisexual MSM, according to findings from a recently published study led by researchers at the University of California Los Angeles.
JULY 11, 2024
